Faculty & Disclosures
Dr Wanda Phipatanakul
Boston Children’s Hospital, Harvard, MA, USA
Wanda Phipatanakul is the director of the Division of Immunology Research Center at Boston Children’s Hospital and Westonian endowed professor of paediatrics at Harvard Medical School. read more
Dr Phipatanakul conducts both school- and home-based asthma studies in children and has had continuous National Institutes of Health (NIH) funding for 20 years. She leads the National Institute of Allergy and Infectious Diseases (NIAID) School Inner-City Asthma Intervention Study; the National Heart, Lung, and Blood Institute (NHLBI) Environment Assessment of Sleep in Youth; the NIAID-funded PARK study evaluating omalizumab in preventing the atopic march and asthma; and a NIAID IDEA study evaluating the response to dupilumab in patients carrying the Interleukin (IL)-4 receptor alpha R576 gene variant. She leads her centre as paediatric principal investigator in multiple NHLBI asthma and prevention networks, including the Severe Asthma Research Program, the Precise Severe Asthma Network, the Atopic Dermatitis Research Network and the Childhood Asthma in Urban Settings Network.
She has authored over 300 publications in scientific journals, including JAMA and the New England Journal of Medicine. She serves on the board of directors of the American Academy of Allergy, Asthma, and Immunology and the American Board of Allergy and Immunology. She also serves as associate editor for the Journal of Allergy and Clinical Immunology (JACI) and on the editorial board for several other journals including JACI: in Practice and Chest.
Dr Wanda Phipatanakul discloses: Advisory board or panel fees from AstraZeneca, Genentech, GlaxoSmithKline, Novartis, Regeneron Pharmaceuticals and Sanofi.
Dr Ioanna Tsiligianni
University of Crete, Crete, Greece
Ioanna Tsiligianni is an associate professor in general practice and public health, in the Department of Social Medicine, Faculty of Medicine, University of Crete. She is the past president (2018–2020) of the International Primary Care Respiratory Group (IPCRG). read more
Dr Tsiligianni’s research centres mainly on public health and primary care issues, with a special focus on primary care respiratory medicine, chronic obstructive pulmonary disease (COPD), asthma and lung cancer.
Ioanna Tsiligianni was chair of the IPCRG World Conference in 2014, and coordinated the development of the first national guidelines for primary care in COPD and asthma in Greece. She is the editor-in-chief of Primary Care Respiratory Medicine.
She is an active member of several organizations, including the European Rural and Isolated Practitioners Association (EURIPA), the International Institute of Compassionate Care and the European Respiratory Society (ERS).
She has more than 170 publications and she is the recipient of 17 awards at international and national level.
Dr Ioanna Tsiligianni discloses: Advisory board or panel fees from Boehringer Ingelheim (relationship terminated) and Novartis (relationship terminated). Grants/Research Support from AstraZeneca (relationship terminated) and GlaxoSmithKline (relationship terminated).
Dr Atul Gupta
King’s College Hospital, London, UK
Atul Gupta is a senior paediatric respiratory consultant at King’s College Hospital & King’s College London. read more
Dr Gupta is head of the department and specializes in all areas of paediatric respiratory medicine, including severe asthma. His research interests centre on asthma, airway disease and respiratory infections. He has published over 175 papers on a range of respiratory-related conditions.
Dr Gupta has received the Lorber Prize, awarded by the Royal College Of Paediatrics and Child Health; The James Fellowship, awarded by the British Medical Association; VASR Memorial Gold Medal; and S.S Manchanda Research Gold Medal.
Dr Atul Gupta discloses: Advisory board or panel fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Novartis Pharmaceuticals. Grants/research support from Airosnett, Boehringer Ingelheim, GlaxoSmithKline and Novartis Pharmaceuticals.
Ms Viv Marsh
Dudley Respiratory Group, West Midlands, UK
Viv Marsh qualified as a registered general nurse (RGN) in 1991 and as a registered sick children’s nurse (RSCN) in 1993, and since then has worked in acute paediatrics, school nursing, specialist nursing and clinical education. read more
In her current National Health Service (NHS) role, Ms Marsh works with the Dudley Respiratory Group supporting the development of integrated services and standards for paediatric asthma care. As the clinical lead for Children and Young People’s Asthma Transformation, she is responsible for the implementation and delivery of the national bundle of asthma care across the Black Country, West Midlands. In her role as the facilitation coordinator for the IMP²ART Trial, she works with the research team and general practitioner practices to deliver the implementation strategy to improve supported self-management of asthma.
Ms Marsh sits on the committee for the National Paediatric Respiratory and Allergy Nurses Group (NPRANG), and is a member of the Primary Care Respiratory Society’s Education Committee.
Ms Viv Marsh discloses: Advisory board or panel fees from Allergy Therapeutics. Speaker’s bureau fees from Napp Pharmaceuticals
Ms Monique Cooper
Miami, FL, USA
Monique Cooper is a parent advocate to those who have children with asthma, attention deficit hyperactivity disorder (ADHD) and anxiety. read more
Monique is co-author of a children’s book series about her son’s disabilities. She co-founded the Javan Allison Foundation after gaining certification to bring awareness to mental health and anxiety, and she is the founder of Success Starts with Me, a mentoring programme for children. Monique continues to tackle several projects empowering children like her son, Javan, who suffer from the three As (asthma, anxiety and ADHD).
Because of her great work in the community, Monique has been honoured by the city of Miami Gardens as one of the “Ordinary Women, doing Extraordinary Things”.
Ms Monique Cooper has no interests/relationships or affiliations to disclose in relation to this activity.
Feedback
We’d love to hear your feedback on this activity. It helps us to continually improve our products.
CORRECT!
